Brawn Laboratories Limited Meloxicam Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Meloxicam Export Records India — #12 Exporter, 32 Shipments, $738.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Meloxicam

India Pharmaceutical Trade Intelligence

$199.4M277 Suppliers100 CountriesHS 30049066

ExportsIndia → UNITED STATES86.3%India → SERBIA3.0%

ImportsUNITED STATES → India$1.1M GERMANY → India$19.9K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Brawn Laboratories Limited — Meloxicam Exporter #12 | $738.4K Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Meloxicam Exporter Profile

Indian Pharmaceutical Exporter · #12 for Meloxicam · $738.4K export value · DGFT Verified

Brawn Laboratories Limited is the #12 Indian exporter of Meloxicam with $738.4K in export value and 32 verified shipments. Brawn Laboratories Limited holds a 0.4% market share in Meloxicam exports across 5 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Meloxicam Export Profile: Buyers & Destinations

Brawn Laboratories Limited Meloxicam export treemap — buyers and destination countries | TransData Nexus

Where Does Brawn Laboratories Limited Export Meloxicam?

Country	Value	Shipments	Share
VIETNAM, DEMOCRATIC REP. OF	$461.8K	17	64.6%
VIETNAM DEMOCRATIC REP. OF	$101.0K	4	14.1%
VIETNAM	$100.0K	2	14.0%
TURKEY	$22.6K	3	3.2%
THAILAND	$14.1K

Who Are the Top Buyers of Meloxicam from Brawn Laboratories Limited?

Buyer	Country	Value	Orders
SAIGON THUONG TIN COMMERCIAL	VIETNAM, DEMOCRATIC REP. OF	$202.5K	6
MILITARY COMMERCIAL JOINT STOCK	VIETNAM, DEMOCRATIC REP. OF	$101.2K	7
A MY PHARMACEUTICAL COMPANY LIMITED	VIETNAM, DEMOCRATIC REP. OF	$100.0K	2
SAIGON THUONG TIN COMMERCIAL JOINT STOCK BANK	VIETNAM	$100.0K	2
SACOMBANK	VIETNAM, DEMOCRATIC REP. OF	$54.6K	2
ASIA COMMERCIAL BANK	VIETNAM, DEMOCRATIC REP. OF	$50.0K	1
ASIA COMMERCIAL BANK.	VIETNAM, DEMOCRATIC REP. OF	$50.0K	1
OMEGA CARE COMPANY	TURKEY	$22.6K	3
GRACE WIN COMPANY LIMITED	MYANMAR	$14.1K	3
IBN SINA SCIENTIFIC BUREAU AL	IRAQ	$12.3K	2

Brawn Laboratories Limited supplies Meloxicam to 13 buyers globally. The largest buyer is SAIGON THUONG TIN COMMERCIAL (VIETNAM, DEMOCRATIC REP. OF), followed by MILITARY COMMERCIAL JOINT STOCK (VIETNAM, DEMOCRATIC REP. OF) and A MY PHARMACEUTICAL COMPANY LIMITED (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Meloxicam Formulations Does Brawn Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
EACH FILM COATED TABLET CONTAINS:MELOXICAM B.P. 7.5MG	$152.5K	5
MELOXICAM TABLETS BP 7.5 MG	$150.0K	3
MELOXICAM TABLETS BP 7.5 MGNOS	$101.2K	6
MELOXICAM TABLETS BP 7.5 MG B/NO.BNT012	$100.0K	2
MELOXICAM TABLETS BP 7.5MG ,B.NO:BNT0822	$50.0K	1
MELOXICAM TABLETS BP 7.5MG-B/NO.BNT09220	$50.0K	1
MELOXICAM TABLETS BP 7.5MG-B/NO.BNT11220	$50.0K	1
MELOXICAM INJECTION BP 15MG / 1.5ML-BR	$15.9K	1
MELOXICAM TABLETS BP 15MGBATCH#BNT0823048D/M-08/23D/E-07/26	$6.8K	1
MELOXICAM TABLETS BP 7.5MG	$5.9K	1

Brawn Laboratories Limited exports 21 distinct Meloxicam formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EACH FILM COATED TABLET CONTAINS:MELOXICAM B.P. 7.5MG with 5 shipments worth $152.5K.

How Does Brawn Laboratories Limited Compare to Nearest Meloxicam Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	STRIDES PHARMA SCIENCE LIMITED	$781.6K	73	2	$10.7K
10	ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED	$750.0K	15	2	$50.0K
12	BRAWN LABORATORIES LIMITED ★	$738.4K	32	5	$23.1K
13	ZIM LABORATORIES LIMITED.	$564.4K	20	4	$28.2K
14	PROSFORA TECHNOLOGIES PRIVATE LIMITED	$538.9K	24	1	$22.5K

Brawn Laboratories Limited ranks #12 among 277 Indian Meloxicam exporters. Average shipment value of $23.1K compared to the market average of $227.2K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED.

Which Indian Ports Ship Meloxicam Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	583	17.7%
JNPT/ NHAVA SHEVA SEA	374	11.3%
SAHAR AIR	370	11.2%
SAHAR AIR CARGO ACC (INBOM4)	276	8.4%
JNPT	242	7.3%
NHAVA SHEVA	147	4.5%
MUNDRA SEA	137	4.2%
Bombay Air	117	3.5%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Meloxicam Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Meloxicam shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 33 individual customs records matching Brawn Laboratories Limited exporting Meloxicam, covering 21 formulations to 7 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 566+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Meloxicam

Meloxicam

Brawn Laboratories Limited — Meloxicam Exporter Profile

Brawn Laboratories Limited — Meloxicam Export Profile: Buyers & Destinations

Where Does Brawn Laboratories Limited Export Meloxicam?

Who Are the Top Buyers of Meloxicam from Brawn Laboratories Limited?

What Is India's Total Meloxicam Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Meloxicam Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Meloxicam Exporters?

What Meloxicam Formulations Does Brawn Laboratories Limited Export?

How Does Brawn Laboratories Limited Compare to Nearest Meloxicam Exporters?

Which Indian Ports Ship Meloxicam Exports?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Meloxicam Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Meloxicam Export Data from Brawn Laboratories Limited

Meloxicam Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source